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Abstract
Purpose To validate a new low-dose and rapid stepwise
individualized algorithm for non-invasive assessment of
ischemic coronary artery disease by sequential use of
prospectively ECG-triggered low-dose CT coronary angiog-
raphy (CTCA) and low-dose single-photon emission comput-
ed tomography myocardial perfusion imaging (SPECT-MPI).
Methods Forty patients referred for elective invasive
coronary angiography (CA) were prospectively enrolled to
undergo a comprehensive non-invasive evaluation with
low-dose CTCA and a dose-reduced stress/rest SPECT-
MPI scan (using dedicated reconstruction algorithms for
low count scans). The following algorithm was reviewed:
CTCA first, followed by a stress-only MPI if a coronary
stenosis (≥ 50% diameter narrowing) or equivocal findings
were observed. Only abnormal stress MPI scans were
followed by rest MPI. The accuracy of the individualized
algorithm to predict coronary revascularization and its
mean effective radiation dose were assessed.
Results CTCA documented CAD in 18 and equivocal
findings in two patients, thus, requiring additional stress
MPI scans. Of these, 16 were abnormal, therefore requiring
a rest MPI scan, revealing ischemia in 15 patients.
Sensitivity, specificity, negative and positive predictive
value, and accuracy of the individualized algorithm for
predicting coronary revascularization was 93.3%, 96.0%,
96.0%, 93.3% and 95.0% on a per-patient base. The mean
effective radiation dose was significantly lower for the
individualized (4.8±3.4 mSv) versus the comprehensive
method (8.1±1.5 mSv) resulting in a total population
radiation dose reduction of 132.6 mSv.
Conclusion This new individualized low-dose algorithm
allows rapid and accurate prediction of invasive CA
findings and of treatment decision with minimized radiation
dose.
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Introduction
In Western countries, coronary artery disease (CAD) is one of
the major causes for morbidity and mortality. So far, invasive
coronary angiography (CA) is the standard of reference for
detection of CAD, although it is costly and associated with a
non-negligible rate of procedural morbidity and mortality [1,
2]. Therefore, great efforts have been made to develop new
non-invasive approaches for imaging coronary atherosclero-
sis. A widely used and well-established diagnostic tool for
detecting ischemia is myocardial perfusion imaging (MPI)
with single photon emission computed tomography (SPECT)
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[3]. However, it does not offer anatomic information for
targeting revascularization. A recently introduced non-
invasive imaging method is computed tomography coronary
angiography (CTCA) [4], which permits visualization of the
coronary arteries and stenoses. Since 1999, when the first
multislice spiral computed tomography was made available
[5], this method has been developed continuously [4]. CTCA
has a high negative predictive value (NPV) but does not
provide functional information on lesion severity as reflected
by its modest positive predictive value (PPV) [6, 7], which has
affected its role in the clinical management in daily routine.
A combination of SPECT-MPI with CTCA has therefore
been suggested, as it would overcome the shortcomings of
each technique and allow comprehensive anatomical and
functional CAD assessment. Although feasibility [8, 9] and
the potential added clinical value of non-invasive imaging
combining MPI with CTCA has been documented [10], the
practicability is so far hampered due to a total radiation
burden up to 41 mSv [11] and long duration of the protocol.
Hence, there is an ongoing debate about the necessity
and the correct indication of the combination of these two
non-invasive diagnostic methods. Recent developments
including prospective ECG-triggering allowing low-dose
CTCA [12, 13] and improved reconstruction algorithms
allowing tracer dose reduction for SPECT-MPI [14]
represent important contributions which may shift the
balance from harms towards benefits.
Using the latest technical refinements to ensure low
effective radiation dose from CTCA (prospective trigger-
ing) and from SPECT-MPI (new reconstruction algorithm
for low counts scanning) we aimed at evaluating the
accuracy to assess CAD and the radiation dose of a
sequential algorithm in which the result of each diagnostic
step determined whether an additional test was necessary
within the following sequence: CTCA, SPECT-MPI at
stress, and SPECT-MPI at rest.
Materials and methods
Study population
Forty patients with low to intermediate pretest probability
who were referred for elective invasive CA due to
suspected CAD were prospectively enrolled to undergo a
low-dose CTCA and a low-dose stress/rest SPECT-MPI
scan on the same day. Exclusion criteria were: known
CAD, hypersensitivity to iodinated contrast material, renal
insufficiency (creatinine levels >150µmol/l), non-sinus
rhythm, or hemodynamic instability. Patients and invasive
cardiologists in the catheterization laboratory were unaware
of the CTCA and stress/rest SPECT-MPI results. The study
protocol was approved by the institutional review board
(local ethics committee of the University Hospital Zurich)
and written informed consent was obtained from each
patient.
Proposed algorithm
After completing all non-invasive CTCA and stress/rest MPI
scans in each patient we reviewed an individualized algorithm
using the following optimized stepwise approach: First,
CTCA findings were analyzed. Second, stress-only SPECT-
MPI was added if at least one coronary stenosis (≥ 50%
diameter narrowing) or equivocal findings were observed by
CTCA. Third, rest MPI was included into the analysis if stress
MPI revealed abnormal findings. Accuracy of this individu-
alized algorithm to predict decisions of the interventional
cardiologists with regard to perform percutaneous coronary
intervention (PCI) in the catheterization laboratory based on
CA and clinical information was assessed. These decisions
served as standard of reference.
CTCA data acquisition and analysis
CTCA scans were performed on a stand-alone LightSpeed
VCT XT scanner (GE Healthcare) using prospective ECG-
triggering as recently established [12] and validated [15].
By choosing the smallest possible window at only one
distinct end-diastolic phase of the RR-cycle (i.e., 75%, with
a padding of 0 ms) and by adapting the tube current and
voltage to the body-mass index (BMI) [16] we ascertained
the lowest achievable effective radiation dose delivery. If
necessary, patients received intravenous metoprolol (5 to
20 mg) (Metoprolol, AstraZeneca, London, UK) to achieve
a target heart rate <63 bpm. Any step artifact was
categorized as non-diagnostic. Two readers experienced in
cardiac radiology blinded for the SPECT-MPI results
assessed all coronary vessels for the presence of significant
stenosis, defined as narrowing of the coronary luminal
diameter≥50%.
SPECT-MPI data acquisition and analysis
Adenosine stress and tracer injection was performed while the
patient was lying on the scanner. Adenosine stress/rest
SPECT-MPI was acquired immediately (i.e., <5 min) after
tracer injection on a dual-head detector camera (Ventri, GE
Healthcare, Milwaukee, USA) to shorten total protocol time,
as recently established [17], without the standard 90 min
delay between tracer application and SPECT-MPI acquisi-
tion. The SPECT-MPI imaging period was approximately
15 min for stress and rest each. As previously validated [14],
a new dedicated iterative algorithm (Evolution for Cardiac,
GE Healthcare), allowing a 50% tracer reduction by
compensating for low count imaging was used for image
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reconstruction on a Xeleris workstation (GE Healthcare).
Accordingly, we used half of the recommended standard
99mTc-tetrofosmin activity adapted to the BMI for stress and
rest (i.e., BMI<25 kg/m2: stress 150 MBq, rest 450 MBq;
BMI≥25 kg/m2: stress 200 MBq, rest 600 MBq). An
unenhanced CT scan was used for soft-tissue attenuation
correction. Image analysis was performed using standard
software according to clinical practice as previously reported
[6, 7], blinded for the CTCA findings.
Effective radiation dose
Effective radiation dose for CTCA was estimated as
dose-length product (DLP) times a conversion coeffi-
cient for the chest k. The commonly used conversion
factor is k ¼ 0:014 mSv=mGy cm [18]. However, we
chose a higher factor, i.e., k ¼ 0:017 mSv=mGy cm [19]
to account for the higher susceptibility of females to breast
cancer as we included 17 females in our study. Radiation
dose for SPECT MPI was calculated as 99mTc-tetrofosmin
activity times 7.9 mSv/GBq as suggested by the
International Commission on Radiological Protection
(ICRP) [20]. For invasive CA (diagnostic part only),
dose-area product (DAP) was multiplied with a conversion
factor for chest k ¼ 0:22 mSv=mGy cmð Þ according to
the National Radiological Protection Board tables [21].
Total and mean effective radiation dose of the individu-
alized algorithm for all patients was compared to the
radiation dose if all tests would have been applied to all
patients.
Invasive coronary angiography data acquisition
and analysis
Experienced interventional cardiologists performed inva-
sive CA in the catheterization laboratory. A coronary
stenosis was defined as a diameter reduction of ≥50% by
visual assessment. The decision towards percutaneous
coronary intervention (PCI) was made by the interventional
cardiologists during CA. This decision was based on an
integration of anatomic coronary lesion findings with the
previously assessed clinical information which had origi-
nally triggered the referral for invasive CA. The operators
were blinded for the information obtained in the non-
invasive part of the study (CTCA, SPECT-MPI).
Statistical analysis
Results from the individualized algorithm were compared
to the decision made by the interventional cardiologist
towards coronary revascularization per patient and per
vessel territory. Sensitivity, specificity, PPV, NPV, and
accuracy were calculated for the individualized algorithm
to predict revascularization decision. P-values of the
difference between the two mean effective radiation doses
were calculated using aWilcoxon signed ranks test. P-values
of less than 0.05 were considered statistically significant.
All P-values are two-sided. SPSS software (SPSS 15.0,
SPSS Inc.) was used for statistical testing.
Results
Each examination, i.e., CTCA, SPECT-MPI and invasive
CA was successfully performed in all 40 patients. Baseline
characteristics of all patients included in this study are
given in Table 1.
Algorithm
Figure 1 displays the individualized rapid low-dose
algorithm. Twenty patients had no significant stenosis in
CTCA (including nine with normal coronaries and 11 with
non-obstructive coronary atherosclerosis) and therefore no
further diagnostic test was needed. In two patients with
equivocal findings, a stress SPECT-MPI was added, which
was normal and, therefore, no rest MPI deemed necessary.
Similarly, stress SPECT-MPI was added in 18 patients with
at least one stenosis (in total there were 56 lesions) in
CTCA, revealing an abnormal finding in 16 patients
triggering the request for a rest SPECT-MPI. The latter
documented total (n=9) or partial (n=6) reversibility of the
defect in 15 patients, indicating ischemia. In one patient,
the resting scan documented a fixed defect, reflecting a
scar. Sensitivity, specificity, NPV, PPV, and accuracy of the
individualized algorithm for predicting coronary revascu-
larization was 93.3%, 96.0%, 96.0%, 93.3% and 95.0% per
Table 1 Baseline characteristics (n=40)
Mean age ± SD (years) 62±8.3
Male (n) 23
Mean body-mass index ± SD (kg/m2) 27.1±5.1
CvRF
Positive family history (%) 35
Smoking (%) 40
Diabetes (%) 13
Hypertension (%) 63
Dyslipidemia (%) 50
Typical chest pain (%) 50
Atypical chest pain (%) 45
Dyspnea (%) 20
SD Standard deviation, CvRF Cardiovascular risk factors
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patient and 90.0%, 95.0%, 97.9%, 78.3% and 94.0% per
vessel territory.
Invasive coronary angiography
Interventional cardiologists decided to perform a PCI in 21
coronary lesions of 15 patients.
Effective radiation dose
The mean effective radiation dose from the non-invasive
imaging study was 8.1±1.5 mSv per patient if all three steps of
the diagnostic algorithm were applied, adding up to
325.7 mSv total effective radiation dose applied to the entire
study population (Fig. 2). By using the individualized
algorithm the mean effective radiation dose was significantly
lower (4.8±3.4 mSv) as less than half of the patients needed
all diagnostic steps. This reduced the total effective radiation
dose deployed to the patient population by 132.6 mSv to
193.1 mSv (p<0.001). The mean effective radiation dose
from CTCA, which would be performed in all 40 patients,
was 2:1 0:7 mSv DLP 120:8 43:2 mGycmð Þ. Radiation
from stress-only SPECT-MPI, which would be required in
20 patients, was 1.4±0.2 mSv resulting from 99mTc-
tetrofosmin activity (207.6±33.7 MBq) and 1.1±0.1 mSv
from the unenhanced CT for attenuation correction (DLP
62.6±6.1 mGycm), adding up to 2.5±0.2 mSv. Rest SPECT-
MPI, requested in 16 patients, resulted in a mean radiation
dose of 3:9 0:5 mSv 557:2 74:7MBqð Þ.
Mean effective radiation dose from purely diagnostic
invasive CA (8.7±4.2 mSv; DAP 39.5±19.1 mGycm2) was
comparable to the unselective combination of CTCA with
stress/rest SPECT-MPI, but significantly higher than the
mean effective radiation obtained from the individualized
algorithm (p<0.001).
Discussion
Our results document that the proposed individualized rapid
algorithm for assessing CAD in patients with low to
intermediate pretest likelihood has an excellent ability to
either rule out functionally relevant stenoses or to predict
the necessity of revascularization procedure despite mini-
mized radiation dose exposure. This is remarkable as both
non-invasive components, i.e., CTCA and SPECT-MPI,
were performed with latest techniques allowing for massive
reduction in total effective radiation dose. Prospective
ECG-triggering has allowed to substantially reduce radia-
tion dose of CTCA from about 15 to 20 mSv down to 1 to
3 mSv at maintained image quality [12] and accuracy [15,
22]. The estimated radiation dose from CTCA in the
present study (2.1±0.7 mSv) lies well within this previous-
ly reported range. Similarly, we have minimized the
radiation dose from SPECT-MPI by using a dedicated
iterative reconstruction algorithm allowing to inject half of
the standard isotope activity. Another strength of the
present algorithm lies in the fact that following the stepwise
approach has prevented many patients from undergoing the
whole sequence of the non-invasive tests, which resulted in
a further significant decrease in radiation burden of the
entire study population.
Several studies have documented the complementary
information provided by the two non-invasive diagnostic
methods CTCA and SPECT MPI [6, 22, 23]. We suggest an
algorithm starting with CTCA first. In our study, 50% of all
patients could be excluded correctly after CTCA from further
tests. This reflects the high NPV of 64-slice CTCA, which
was demonstrated in earlier studies [6, 15]. The ability to
rule out correctly CAD and therefore to appropriately avoid
the need of additional diagnostic methods renders CTCA an
excellent tool for starting the diagnostic algorithm in patients
Fig. 1 Individualized low-dose
algorithm showing decisions
made in the study population
(CA invasive coronary
angiography, CAD coronary
artery disease, CTCA computed
tomography coronary
angiography, MPI myocardial
perfusion imaging)
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with low to intermediate pretest probability. By contrast, an
abnormal 64-slice CTCA is a poor predictor of functionally
relevant coronary stenoses [6]. Patients with positive CTCA
should undergo further evaluation for obstructive CAD to
ensure the physiological relevance of the lesion. Conse-
quently, CTCA is not recommended as the first diagnostic
step in patients with elevated probability of CAD or those
with advanced age as the latter confers a higher prevalence
of severe coronary calcifications which both severely impairs
the NPVof CTCA. Thus, our findings would not necessarily
hold true when extrapolated to other patient populations with
higher disease prevalence for which the algorithm may need
appropriate modifications.
In the present study, less than half of the patients needed
all diagnostic steps, indicating that our algorithm was
adequately used in the appropriate target population with
low to intermediate pretest probability. As a consequence,
total radiation dose to the study population was significant-
ly reduced by about 50%, resulting in an average effective
radiation dose of 4.8±3.4 mSv per patient. This represents a
dose reduction in the range of a power of magnitude
compared to earlier studies combining SPECT-MPI with
CTCA reaching values of 41 mSv [11]. This is likely to
have a major clinical impact, as the balance of harms and
benefits is clearly shifted to the favorable end and therefore
such combined and accurate non-invasive assessment of
CAD will gain importance. This is further elucidated by the
fact that almost two-thirds of all patients referred to
invasive evaluation in Europe will end up with a purely
diagnostic invasive CA [24]. The morbidity and mortality
associated with the invasiveness of the diagnostic CA may
be increasingly perceived as unjustified in view of valuable
non-invasive alternatives. This is particularly true as the
radiation burden of the latter was for a long time regarded
as prohibitively high, but has now been massively reduced.
In fact, our results document that with the latest technical
refinements associated with appropriate and well-selected
individualized use the resulting dose is reasonably low,
comparable to half of the radiation obtained from diagnos-
tic invasive CA.
We acknowledge the following limitations: First, this is a
single-center study with only a small population of 40
patients. Therefore, the results of this hypothesizing
generating pilot study may require confirmation in larger
studies. Second, the present results must be read with
caution when generalized to patient populations with
disease prevalence different from our population. In fact,
in high-prevalence populations the algorithm would need
adjustments as ischemia assessment may preferably precede
any structural assessment such as CTCA. Furthermore,
sinus rhythm and heart rate control is required for
prospective ECG-triggering [12], which explains why
beta-blockers where administered frequently, although this
was comparable to previous reports [12, 13]. Although
some concerns have been raised on whether beta-blockade
may reduce the extent and severity of SPECT-MPI, a recent
systematic study has ruled out any effect of beta-blocker
treatment on accuracy of SPECT-MPI [25]. Finally,
although an individualized algorithm may be favorable for
the individual patient, this may not be ideal for aspects of
practicability, as in a busy site image reporting may not be
available fast enough to allow online decisions with regard
to next step scanning. Furthermore, even if such continuous
decision-making would be available, it may be a challenge
for many sites to implement such flexible schedules for
reasons of scanner and radioligand availability.
In conclusion, this study shows that despite minimized
radiation dose, the proposed low-dose stepwise rapid
Fig. 2 Comparison of mean and total effective radiation dose for the individualized versus the non-selective algorithm (CTCA computed
tomography coronary angiography, MPI myocardial perfusion imaging, STOP no further test required). *p<0.001
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algorithm accurately predicts which decision with regard to
revascularization would be taken in the catheterization
laboratory.
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